Share Price and Basic Stock Data
Last Updated: October 22, 2025, 8:21 am
| PEG Ratio | -1.45 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Camex Ltd, operating in the specialty chemicals sector, reported a current market price of ₹38.5 and a market capitalization of ₹39.3 Cr. The company has shown fluctuating revenue trends over the past few quarters, with sales recorded at ₹39.72 Cr in March 2022, dipping to ₹30.33 Cr in December 2022. However, there was a rebound in sales, reaching ₹40.36 Cr in March 2023. The latest quarterly report indicates sales of ₹35.22 Cr for September 2023, reflecting a moderate recovery. Over the past fiscal year ending March 2023, total sales stood at ₹132 Cr, a decline from ₹162 Cr in March 2022, indicating a need for strategic adjustments to stabilize revenue. The sales figure for the upcoming fiscal year (March 2024) is anticipated to be around ₹142 Cr. This trend signifies the challenges the company faces in maintaining consistent growth amidst market fluctuations.
Profitability and Efficiency Metrics
Camex Ltd’s profitability metrics illustrate a mixed performance. The operating profit margin (OPM) stood at a low of 1.24% in March 2023, but improved to 5.54% by March 2025. This upward trajectory in OPM indicates enhanced operational efficiency. Net profit for the latest fiscal year was reported at ₹2 Cr, translating to an earnings per share (EPS) of ₹0.15. The return on equity (ROE) was recorded at 4.63%, while the return on capital employed (ROCE) stood at 9.07%, reflecting the company’s ability to generate returns on shareholders’ equity and capital employed, respectively. The interest coverage ratio (ICR) at 2.34x suggests that the company maintains a comfortable buffer over interest obligations. However, the cash conversion cycle of 51 days indicates potential inefficiencies in working capital management, requiring attention to improve liquidity and operational effectiveness.
Balance Sheet Strength and Financial Ratios
Camex Ltd maintains a relatively strong balance sheet with total reserves of ₹33 Cr against borrowings of ₹1 Cr, indicating a low debt burden and a debt-to-equity ratio that supports financial stability. The current ratio is notably high at 3.74, suggesting robust liquidity, enabling the company to meet short-term obligations comfortably. The price-to-book value (P/BV) ratio is recorded at 0.71x, indicating that the stock may be undervalued compared to its book value, a positive sign for potential investors. However, the company’s profitability metrics, with an operating profit of ₹4 Cr and a net profit margin of 1.77% in March 2022, show that while revenues have declined, operational efficiency has improved over time. The overall financial ratios indicate a cautious but stable financial position, although improvements are necessary to enhance overall profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Camex Ltd reveals that promoters hold 44.76% of the company, a decrease from 58.28% in September 2022, indicating a dilution of control. Institutional investors (DIIs) hold a minimal stake of 0.01%, while the public holds 55.24%. The total number of shareholders has fluctuated, with 3,976 recorded as of June 2025. This significant public ownership can be interpreted as a positive sign for liquidity and market participation. However, the decline in promoter holdings may raise concerns regarding investor confidence. The low institutional interest suggests a lack of external validation for the company’s performance, which could impact future capital raising efforts. The stability of the public shareholding could serve as a buffer against volatility, but the overall sentiment might lean towards caution given the changing dynamics of the ownership structure.
Outlook, Risks, and Final Insight
If margins sustain their upward trend, Camex Ltd could improve its profitability, capitalizing on operational efficiencies. However, the company faces several risks, including reliance on fluctuating demand in the specialty chemicals market and potential operational inefficiencies indicated by the cash conversion cycle. The dilution of promoter holdings may also signal a shift in strategic direction or management confidence, which could affect stock performance. Additionally, the low institutional interest raises concerns about the company’s perceived attractiveness to larger investors. If the company can enhance its operational efficiencies and stabilize revenues, it may attract greater investor interest and improve share price performance. Overall, while the company shows potential for recovery, addressing these risks will be crucial for sustaining growth and enhancing shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Camex Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 430 Cr. | 46.8 | 88.0/42.6 | 26.2 | 20.0 | 0.85 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 39.8 Cr. | 81.0 | 104/56.0 | 17.8 | 87.4 | 1.23 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 48.6 Cr. | 715 | 1,178/600 | 52.8 | 670 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 4,043 Cr. | 89.2 | 114/78.0 | 26.9 | 20.7 | 0.56 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 757 Cr. | 304 | 453/241 | 27.1 | 91.1 | 0.82 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 13,171.00 Cr | 756.28 | 48.15 | 178.12 | 0.40% | 12.99% | 25.41% | 6.44 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.72 | 30.61 | 30.58 | 30.33 | 40.36 | 34.13 | 35.22 | 34.37 | 37.59 | 33.84 | 34.39 | 28.21 | 37.21 |
| Expenses | 40.21 | 29.97 | 31.03 | 30.76 | 39.86 | 34.42 | 34.11 | 33.15 | 35.49 | 32.95 | 33.01 | 28.58 | 35.15 |
| Operating Profit | -0.49 | 0.64 | -0.45 | -0.43 | 0.50 | -0.29 | 1.11 | 1.22 | 2.10 | 0.89 | 1.38 | -0.37 | 2.06 |
| OPM % | -1.23% | 2.09% | -1.47% | -1.42% | 1.24% | -0.85% | 3.15% | 3.55% | 5.59% | 2.63% | 4.01% | -1.31% | 5.54% |
| Other Income | 3.68 | 0.39 | 0.58 | 0.35 | 0.62 | 0.37 | 0.44 | 0.52 | 0.25 | 0.33 | 1.15 | 0.29 | -1.01 |
| Interest | 0.46 | 0.26 | 0.18 | 0.34 | 0.23 | 0.25 | 0.21 | 0.12 | 0.18 | 0.33 | 0.45 | 0.31 | 0.24 |
| Depreciation | 0.19 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.09 | 0.35 |
| Profit before tax | 2.54 | 0.69 | -0.13 | -0.50 | 0.81 | -0.25 | 1.26 | 1.54 | 2.09 | 0.82 | 2.01 | -0.48 | 0.46 |
| Tax % | 16.93% | 26.09% | -46.15% | -14.00% | 23.46% | 0.00% | 21.43% | 24.68% | 25.84% | 24.39% | 27.36% | -35.42% | 69.57% |
| Net Profit | 2.10 | 0.51 | -0.08 | -0.44 | 0.62 | -0.24 | 0.99 | 1.16 | 1.55 | 0.61 | 1.46 | -0.32 | 0.15 |
| EPS in Rs | 2.06 | 0.50 | -0.08 | -0.43 | 0.61 | -0.24 | 0.97 | 1.14 | 1.52 | 0.60 | 1.43 | -0.31 | 0.15 |
Last Updated: May 31, 2025, 6:37 am
Below is a detailed analysis of the quarterly data for Camex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 37.21 Cr.. The value appears strong and on an upward trend. It has increased from 28.21 Cr. (Dec 2024) to 37.21 Cr., marking an increase of 9.00 Cr..
- For Expenses, as of Mar 2025, the value is 35.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.58 Cr. (Dec 2024) to 35.15 Cr., marking an increase of 6.57 Cr..
- For Operating Profit, as of Mar 2025, the value is 2.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.37 Cr. (Dec 2024) to 2.06 Cr., marking an increase of 2.43 Cr..
- For OPM %, as of Mar 2025, the value is 5.54%. The value appears strong and on an upward trend. It has increased from -1.31% (Dec 2024) to 5.54%, marking an increase of 6.85%.
- For Other Income, as of Mar 2025, the value is -1.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.29 Cr. (Dec 2024) to -1.01 Cr., marking a decrease of 1.30 Cr..
- For Interest, as of Mar 2025, the value is 0.24 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Dec 2024) to 0.24 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Mar 2025, the value is 0.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Dec 2024) to 0.35 Cr., marking an increase of 0.26 Cr..
- For Profit before tax, as of Mar 2025, the value is 0.46 Cr.. The value appears strong and on an upward trend. It has increased from -0.48 Cr. (Dec 2024) to 0.46 Cr., marking an increase of 0.94 Cr..
- For Tax %, as of Mar 2025, the value is 69.57%. The value appears to be increasing, which may not be favorable. It has increased from -35.42% (Dec 2024) to 69.57%, marking an increase of 104.99%.
- For Net Profit, as of Mar 2025, the value is 0.15 Cr.. The value appears strong and on an upward trend. It has increased from -0.32 Cr. (Dec 2024) to 0.15 Cr., marking an increase of 0.47 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.15. The value appears strong and on an upward trend. It has increased from -0.31 (Dec 2024) to 0.15, marking an increase of 0.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:42 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 221 | 147 | 102 | 103 | 121 | 140 | 122 | 143 | 162 | 132 | 142 | 134 | 134 |
| Expenses | 215 | 141 | 98 | 99 | 116 | 134 | 119 | 140 | 159 | 131 | 137 | 130 | 130 |
| Operating Profit | 7 | 6 | 4 | 4 | 6 | 7 | 3 | 3 | 2 | 1 | 5 | 4 | 4 |
| OPM % | 3% | 4% | 4% | 4% | 5% | 5% | 3% | 2% | 1% | 0% | 3% | 3% | 3% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 5 | 2 | 1 | 1 | 1 |
| Interest | 4 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 |
| Profit before tax | 3 | 2 | 1 | 2 | 3 | 4 | 1 | 2 | 5 | 1 | 5 | 3 | 3 |
| Tax % | 33% | 33% | 33% | 34% | 34% | 23% | 29% | 18% | 17% | 29% | 25% | 32% | |
| Net Profit | 2 | 1 | 1 | 2 | 2 | 3 | 1 | 2 | 4 | 1 | 3 | 2 | 2 |
| EPS in Rs | 1.88 | 1.39 | 0.90 | 1.60 | 2.09 | 3.08 | 0.94 | 1.96 | 4.13 | 0.60 | 3.39 | 1.85 | 2.15 |
| Dividend Payout % | 27% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 0.00% | 100.00% | 0.00% | 50.00% | -66.67% | 100.00% | 100.00% | -75.00% | 200.00% | -33.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 50.00% | 100.00% | -100.00% | 50.00% | -116.67% | 166.67% | 0.00% | -175.00% | 275.00% | -233.33% |
Camex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 2% |
| 3 Years: | -6% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 15% |
| 3 Years: | 0% |
| TTM: | -48% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: July 25, 2025, 1:38 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 10 | 12 | 12 | 14 | 16 | 19 | 20 | 22 | 27 | 27 | 31 | 33 |
| Borrowings | 36 | 19 | 14 | 20 | 29 | 14 | 3 | 17 | 9 | 5 | 8 | 1 |
| Other Liabilities | 10 | 10 | 10 | 11 | 11 | 14 | 17 | 27 | 15 | 16 | 13 | 17 |
| Total Liabilities | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 |
| Fixed Assets | 6 | 7 | 7 | 8 | 9 | 9 | 9 | 8 | 3 | 2 | 2 | 8 |
| CWIP | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 |
| Other Assets | 60 | 43 | 38 | 47 | 57 | 48 | 41 | 69 | 50 | 56 | 59 | 54 |
| Total Assets | 66 | 51 | 46 | 55 | 66 | 57 | 50 | 77 | 60 | 59 | 61 | 62 |
Below is a detailed analysis of the balance sheet data for Camex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
- For Reserves, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 2.00 Cr..
- For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 8.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2024) to 17.00 Cr., marking an increase of 4.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 62.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.00 Cr. (Mar 2024) to 62.00 Cr., marking an increase of 1.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 6.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 54.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2024) to 54.00 Cr., marking a decrease of 5.00 Cr..
- For Total Assets, as of Mar 2025, the value is 62.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2024) to 62.00 Cr., marking an increase of 1.00 Cr..
Notably, the Reserves (33.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -29.00 | -13.00 | -10.00 | -16.00 | -23.00 | -7.00 | 0.00 | -14.00 | -7.00 | -4.00 | -3.00 | 3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 68 | 87 | 98 | 103 | 82 | 77 | 98 | 70 | 82 | 61 | 60 |
| Inventory Days | 18 | 27 | 28 | 44 | 42 | 38 | 31 | 45 | 16 | 31 | 23 | 40 |
| Days Payable | 13 | 25 | 29 | 28 | 21 | 36 | 47 | 71 | 32 | 45 | 32 | 50 |
| Cash Conversion Cycle | 78 | 71 | 86 | 115 | 123 | 83 | 61 | 72 | 54 | 67 | 52 | 51 |
| Working Capital Days | 31 | 40 | 62 | 66 | 69 | 60 | 63 | 79 | 75 | 101 | 84 | 88 |
| ROCE % | 11% | 10% | 8% | 9% | 11% | 12% | 6% | 7% | 7% | 5% | 12% | 9% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Diluted EPS (Rs.) | 3.19 | 1.37 | 1.21 | 3.61 | 2.23 |
| Cash EPS (Rs.) | 3.97 | 2.27 | 2.58 | 4.52 | 3.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 38.95 | 33.24 | 31.93 | 30.55 | 26.81 |
| Revenue From Operations / Share (Rs.) | 175.58 | 147.10 | 129.23 | 144.20 | 126.22 |
| PBDIT / Share (Rs.) | 2.98 | 3.36 | 3.80 | 7.25 | 6.17 |
| PBIT / Share (Rs.) | 2.12 | 2.43 | 2.44 | 6.34 | 5.39 |
| PBT / Share (Rs.) | 3.99 | 1.75 | 1.61 | 4.54 | 3.29 |
| Net Profit / Share (Rs.) | 3.12 | 1.33 | 1.23 | 3.61 | 2.23 |
| NP After MI And SOA / Share (Rs.) | 3.08 | 1.33 | 1.23 | 3.61 | 2.23 |
| PBDIT Margin (%) | 1.69 | 2.28 | 2.93 | 5.02 | 4.89 |
| PBIT Margin (%) | 1.20 | 1.65 | 1.89 | 4.39 | 4.26 |
| PBT Margin (%) | 2.27 | 1.19 | 1.24 | 3.15 | 2.60 |
| Net Profit Margin (%) | 1.77 | 0.90 | 0.95 | 2.50 | 1.76 |
| NP After MI And SOA Margin (%) | 1.75 | 0.90 | 0.95 | 2.50 | 1.76 |
| Return on Networth / Equity (%) | 8.46 | 4.00 | 3.84 | 11.82 | 8.32 |
| Return on Capital Employeed (%) | 4.46 | 5.95 | 7.41 | 18.00 | 14.66 |
| Return On Assets (%) | 4.83 | 1.68 | 2.26 | 5.96 | 3.28 |
| Long Term Debt / Equity (X) | 0.22 | 0.20 | 0.00 | 0.11 | 0.32 |
| Total Debt / Equity (X) | 0.23 | 0.51 | 0.07 | 0.43 | 1.09 |
| Asset Turnover Ratio (%) | 2.29 | 2.16 | 2.19 | 2.22 | 1.95 |
| Current Ratio (X) | 3.74 | 1.85 | 2.10 | 1.99 | 1.86 |
| Quick Ratio (X) | 2.91 | 1.45 | 1.69 | 1.51 | 1.48 |
| Inventory Turnover Ratio (X) | 3.32 | 3.77 | 3.79 | 2.85 | 2.69 |
| Interest Coverage Ratio (X) | 2.34 | 4.98 | 4.56 | 4.04 | 2.95 |
| Interest Coverage Ratio (Post Tax) (X) | 0.98 | 2.97 | 2.48 | 3.01 | 2.07 |
| Enterprise Value (Cr.) | 35.37 | 36.38 | 11.99 | 44.10 | 62.50 |
| EV / Net Operating Revenue (X) | 0.19 | 0.24 | 0.09 | 0.29 | 0.48 |
| EV / EBITDA (X) | 11.63 | 10.59 | 3.09 | 5.96 | 9.91 |
| MarketCap / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| Price / BV (X) | 0.71 | 0.59 | 0.31 | 1.04 | 1.31 |
| Price / Net Operating Revenue (X) | 0.14 | 0.13 | 0.07 | 0.22 | 0.27 |
| EarningsYield | 0.11 | 0.06 | 0.12 | 0.11 | 0.06 |
After reviewing the key financial ratios for Camex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 22, the value is 3.97. This value is within the healthy range. It has increased from 2.27 (Mar 21) to 3.97, marking an increase of 1.70.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
- For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 175.58. It has increased from 147.10 (Mar 21) to 175.58, marking an increase of 28.48.
- For PBDIT / Share (Rs.), as of Mar 22, the value is 2.98. This value is within the healthy range. It has decreased from 3.36 (Mar 21) to 2.98, marking a decrease of 0.38.
- For PBIT / Share (Rs.), as of Mar 22, the value is 2.12. This value is within the healthy range. It has decreased from 2.43 (Mar 21) to 2.12, marking a decrease of 0.31.
- For PBT / Share (Rs.), as of Mar 22, the value is 3.99. This value is within the healthy range. It has increased from 1.75 (Mar 21) to 3.99, marking an increase of 2.24.
- For Net Profit / Share (Rs.), as of Mar 22, the value is 3.12. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.12, marking an increase of 1.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 3.08. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.08, marking an increase of 1.75.
- For PBDIT Margin (%), as of Mar 22, the value is 1.69. This value is below the healthy minimum of 10. It has decreased from 2.28 (Mar 21) to 1.69, marking a decrease of 0.59.
- For PBIT Margin (%), as of Mar 22, the value is 1.20. This value is below the healthy minimum of 10. It has decreased from 1.65 (Mar 21) to 1.20, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 22, the value is 2.27. This value is below the healthy minimum of 10. It has increased from 1.19 (Mar 21) to 2.27, marking an increase of 1.08.
- For Net Profit Margin (%), as of Mar 22, the value is 1.77. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 21) to 1.77, marking an increase of 0.87.
- For NP After MI And SOA Margin (%), as of Mar 22, the value is 1.75. This value is below the healthy minimum of 8. It has increased from 0.90 (Mar 21) to 1.75, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 22, the value is 8.46. This value is below the healthy minimum of 15. It has increased from 4.00 (Mar 21) to 8.46, marking an increase of 4.46.
- For Return on Capital Employeed (%), as of Mar 22, the value is 4.46. This value is below the healthy minimum of 10. It has decreased from 5.95 (Mar 21) to 4.46, marking a decrease of 1.49.
- For Return On Assets (%), as of Mar 22, the value is 4.83. This value is below the healthy minimum of 5. It has increased from 1.68 (Mar 21) to 4.83, marking an increase of 3.15.
- For Long Term Debt / Equity (X), as of Mar 22, the value is 0.22. This value is within the healthy range. It has increased from 0.20 (Mar 21) to 0.22, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 22, the value is 0.23. This value is within the healthy range. It has decreased from 0.51 (Mar 21) to 0.23, marking a decrease of 0.28.
- For Asset Turnover Ratio (%), as of Mar 22, the value is 2.29. It has increased from 2.16 (Mar 21) to 2.29, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 22, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 21) to 3.74, marking an increase of 1.89.
- For Quick Ratio (X), as of Mar 22, the value is 2.91. This value exceeds the healthy maximum of 2. It has increased from 1.45 (Mar 21) to 2.91, marking an increase of 1.46.
- For Inventory Turnover Ratio (X), as of Mar 22, the value is 3.32. This value is below the healthy minimum of 4. It has decreased from 3.77 (Mar 21) to 3.32, marking a decrease of 0.45.
- For Interest Coverage Ratio (X), as of Mar 22, the value is 2.34. This value is below the healthy minimum of 3. It has decreased from 4.98 (Mar 21) to 2.34, marking a decrease of 2.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 0.98. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 21) to 0.98, marking a decrease of 1.99.
- For Enterprise Value (Cr.), as of Mar 22, the value is 35.37. It has decreased from 36.38 (Mar 21) to 35.37, marking a decrease of 1.01.
- For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 21) to 0.19, marking a decrease of 0.05.
- For EV / EBITDA (X), as of Mar 22, the value is 11.63. This value is within the healthy range. It has increased from 10.59 (Mar 21) to 11.63, marking an increase of 1.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For Price / BV (X), as of Mar 22, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 21) to 0.71, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
- For EarningsYield, as of Mar 22, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 21) to 0.11, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camex Ltd:
- Net Profit Margin: 1.77%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.46% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.46% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 17.7 (Industry average Stock P/E: 48.15)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.23
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.77%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Camex House, 2nd Floor, Ahmedabad Gujarat 380009 | cs@camexltd.com http://www.camexltd.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chandraprakash Chopra | Managing Director |
| Mr. Rajesh Nahata | Executive Director |
| Mr. Rahul Chopra | Non Executive Director |
| Mrs. Tara Jain | Ind. Non-Executive Director |
| Mr. Uttam Bhandari | Ind. Non-Executive Director |
| Mr. Jagrit Sanklecha | Additional Director |
FAQ
What is the intrinsic value of Camex Ltd?
Camex Ltd's intrinsic value (as of 22 October 2025) is 28.09 which is 27.97% lower the current market price of 39.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 39.8 Cr. market cap, FY2025-2026 high/low of 70.9/31.5, reserves of ₹33 Cr, and liabilities of 62 Cr.
What is the Market Cap of Camex Ltd?
The Market Cap of Camex Ltd is 39.8 Cr..
What is the current Stock Price of Camex Ltd as on 22 October 2025?
The current stock price of Camex Ltd as on 22 October 2025 is 39.0.
What is the High / Low of Camex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Camex Ltd stocks is 70.9/31.5.
What is the Stock P/E of Camex Ltd?
The Stock P/E of Camex Ltd is 17.7.
What is the Book Value of Camex Ltd?
The Book Value of Camex Ltd is 42.0.
What is the Dividend Yield of Camex Ltd?
The Dividend Yield of Camex Ltd is 0.00 %.
What is the ROCE of Camex Ltd?
The ROCE of Camex Ltd is 9.07 %.
What is the ROE of Camex Ltd?
The ROE of Camex Ltd is 4.63 %.
What is the Face Value of Camex Ltd?
The Face Value of Camex Ltd is 10.0.